Annovis Bio, Inc. (ANVS)
1.705
+0.02
(+0.89%)
USD |
NYSE |
Sep 02, 16:00
1.62
-0.08
(-4.99%)
After-Hours: 20:00
Annovis Bio Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 16.98 |
| June 26, 2026 | 15.70 |
| June 25, 2026 | 15.06 |
| June 24, 2026 | 15.52 |
| June 23, 2026 | 15.88 |
| June 22, 2026 | 16.16 |
| June 18, 2026 | 15.98 |
| June 17, 2026 | 15.88 |
| June 16, 2026 | 16.34 |
| June 15, 2026 | 16.25 |
| June 12, 2026 | 16.25 |
| June 11, 2026 | 16.71 |
| June 10, 2026 | 15.70 |
| June 09, 2026 | 16.16 |
| June 08, 2026 | 16.34 |
| June 05, 2026 | 17.25 |
| June 04, 2026 | 18.17 |
| June 03, 2026 | 16.89 |
| June 02, 2026 | 16.98 |
| June 01, 2026 | 16.61 |
| May 29, 2026 | 17.53 |
| May 28, 2026 | 17.35 |
| May 27, 2026 | 18.35 |
| May 26, 2026 | 18.81 |
| May 22, 2026 | 20.36 |
| Date | Value |
|---|---|
| May 21, 2026 | 19.63 |
| May 20, 2026 | 18.62 |
| May 19, 2026 | 17.71 |
| May 18, 2026 | 18.71 |
| May 15, 2026 | 18.81 |
| May 14, 2026 | 19.44 |
| May 13, 2026 | 20.27 |
| May 12, 2026 | 20.81 |
| May 11, 2026 | 21.82 |
| May 08, 2026 | 20.81 |
| May 07, 2026 | 20.63 |
| May 06, 2026 | 21.91 |
| May 05, 2026 | 20.72 |
| May 04, 2026 | 20.81 |
| May 01, 2026 | 18.26 |
| April 30, 2026 | 17.98 |
| April 29, 2026 | 16.80 |
| April 28, 2026 | 16.89 |
| April 27, 2026 | 17.25 |
| April 24, 2026 | 15.88 |
| April 23, 2026 | 16.52 |
| April 22, 2026 | 16.80 |
| April 21, 2026 | 16.98 |
| April 20, 2026 | 17.53 |
| April 17, 2026 | 17.07 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.811 |
| Alnylam Pharmaceuticals, Inc. | 26.40 |
| Anika Therapeutics, Inc. | 2.103 |
| Savara, Inc. | 7.835 |
| Vericel Corp. | 5.657 |
Price to Book Value Related Metrics
| Price | 1.705 |
| Earnings Yield | -105.1% |
| Market Cap | 72.64M |